Symptom severity, symptom interference and use of complementary and alternative medicine among survivors of colorectal and breast cancer after curative treatment in Taiwan

Hsiu Ju Wu, Chen Jei Tai, Cheng Jeng Tai, Li Yin Chien

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

This study compared symptom severity, symptom interference and use of complementary and alternative medicine (CAM) between cancer survivors after curative treatment and individuals who did not have cancer. Factors associated with CAM use among cancer survivors were examined. A cross-sectional survey was conducted of 146 cancer survivors (77 breast and 69 colorectal cancer survivors who had completed conventional treatment 1–5 years previously and were cancer-free) from a hospital's cancer registration system (survivor group), and 161 healthy individuals without cancer (comparison group). The two groups were frequency-matched for sex and age. Findings indicated higher use of CAM in the survivor group (54.1%) than the comparison group (36.6%). There were no significant differences in overall symptom severity and interference between the two groups. Multivariate logistic regression showed that prior use of CAM (OR = 5.14, 95% CI: 2.34–10.69) and higher symptom interference (OR = 1.04, 95% CI: 1.001–1.08) were positively related to CAM use in the survivor group. The survivors did not have higher symptom severity and symptom interference with daily life, but were more likely to use CAM than the comparison group. Medical staff should discuss symptom interference and use of CAM with cancer survivors to guide them in the appropriate use of CAM.

Original languageEnglish
Article numbere12925
JournalEuropean Journal of Cancer Care
DOIs
Publication statusAccepted/In press - Jan 1 2018

Fingerprint

Complementary Therapies
Taiwan
Colorectal Neoplasms
Breast Neoplasms
Therapeutics
Neoplasms
Cancer Care Facilities
Medical Staff

Keywords

  • cancer survivors
  • complementary and alternative medicine
  • symptom interference
  • symptom severity

ASJC Scopus subject areas

  • Oncology

Cite this

@article{75713284725a42778744dd9de4f383e5,
title = "Symptom severity, symptom interference and use of complementary and alternative medicine among survivors of colorectal and breast cancer after curative treatment in Taiwan",
abstract = "This study compared symptom severity, symptom interference and use of complementary and alternative medicine (CAM) between cancer survivors after curative treatment and individuals who did not have cancer. Factors associated with CAM use among cancer survivors were examined. A cross-sectional survey was conducted of 146 cancer survivors (77 breast and 69 colorectal cancer survivors who had completed conventional treatment 1–5 years previously and were cancer-free) from a hospital's cancer registration system (survivor group), and 161 healthy individuals without cancer (comparison group). The two groups were frequency-matched for sex and age. Findings indicated higher use of CAM in the survivor group (54.1{\%}) than the comparison group (36.6{\%}). There were no significant differences in overall symptom severity and interference between the two groups. Multivariate logistic regression showed that prior use of CAM (OR = 5.14, 95{\%} CI: 2.34–10.69) and higher symptom interference (OR = 1.04, 95{\%} CI: 1.001–1.08) were positively related to CAM use in the survivor group. The survivors did not have higher symptom severity and symptom interference with daily life, but were more likely to use CAM than the comparison group. Medical staff should discuss symptom interference and use of CAM with cancer survivors to guide them in the appropriate use of CAM.",
keywords = "cancer survivors, complementary and alternative medicine, symptom interference, symptom severity, cancer survivors, complementary and alternative medicine, symptom interference, symptom severity",
author = "Wu, {Hsiu Ju} and Tai, {Chen Jei} and Tai, {Cheng Jeng} and Chien, {Li Yin}",
year = "2018",
month = "1",
day = "1",
doi = "10.1111/ecc.12925",
language = "English",
journal = "European Journal of Cancer Care",
issn = "0961-5423",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Symptom severity, symptom interference and use of complementary and alternative medicine among survivors of colorectal and breast cancer after curative treatment in Taiwan

AU - Wu, Hsiu Ju

AU - Tai, Chen Jei

AU - Tai, Cheng Jeng

AU - Chien, Li Yin

PY - 2018/1/1

Y1 - 2018/1/1

N2 - This study compared symptom severity, symptom interference and use of complementary and alternative medicine (CAM) between cancer survivors after curative treatment and individuals who did not have cancer. Factors associated with CAM use among cancer survivors were examined. A cross-sectional survey was conducted of 146 cancer survivors (77 breast and 69 colorectal cancer survivors who had completed conventional treatment 1–5 years previously and were cancer-free) from a hospital's cancer registration system (survivor group), and 161 healthy individuals without cancer (comparison group). The two groups were frequency-matched for sex and age. Findings indicated higher use of CAM in the survivor group (54.1%) than the comparison group (36.6%). There were no significant differences in overall symptom severity and interference between the two groups. Multivariate logistic regression showed that prior use of CAM (OR = 5.14, 95% CI: 2.34–10.69) and higher symptom interference (OR = 1.04, 95% CI: 1.001–1.08) were positively related to CAM use in the survivor group. The survivors did not have higher symptom severity and symptom interference with daily life, but were more likely to use CAM than the comparison group. Medical staff should discuss symptom interference and use of CAM with cancer survivors to guide them in the appropriate use of CAM.

AB - This study compared symptom severity, symptom interference and use of complementary and alternative medicine (CAM) between cancer survivors after curative treatment and individuals who did not have cancer. Factors associated with CAM use among cancer survivors were examined. A cross-sectional survey was conducted of 146 cancer survivors (77 breast and 69 colorectal cancer survivors who had completed conventional treatment 1–5 years previously and were cancer-free) from a hospital's cancer registration system (survivor group), and 161 healthy individuals without cancer (comparison group). The two groups were frequency-matched for sex and age. Findings indicated higher use of CAM in the survivor group (54.1%) than the comparison group (36.6%). There were no significant differences in overall symptom severity and interference between the two groups. Multivariate logistic regression showed that prior use of CAM (OR = 5.14, 95% CI: 2.34–10.69) and higher symptom interference (OR = 1.04, 95% CI: 1.001–1.08) were positively related to CAM use in the survivor group. The survivors did not have higher symptom severity and symptom interference with daily life, but were more likely to use CAM than the comparison group. Medical staff should discuss symptom interference and use of CAM with cancer survivors to guide them in the appropriate use of CAM.

KW - cancer survivors

KW - complementary and alternative medicine

KW - symptom interference

KW - symptom severity

KW - cancer survivors

KW - complementary and alternative medicine

KW - symptom interference

KW - symptom severity

UR - http://www.scopus.com/inward/record.url?scp=85054180795&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054180795&partnerID=8YFLogxK

U2 - 10.1111/ecc.12925

DO - 10.1111/ecc.12925

M3 - Article

AN - SCOPUS:85054180795

JO - European Journal of Cancer Care

JF - European Journal of Cancer Care

SN - 0961-5423

M1 - e12925

ER -